Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Peritoneal metastases remain a significant clinical challenge owing to the immunosuppressive nature of the omentum, which serves as a protective niche for disseminated tumor cells. Our recent study explored the targeted delivery of immunomodulatory cytokine-encoded mRNAs to the omentum, aiming to shift its role from a tumor-supportive site to an immune-activating ally. Our findings highlight the potential of cytokine mRNA delivery as a novel and safe immunotherapeutic strategy for peritoneal metastases.

More information Original publication

DOI

10.1080/2162402x.2025.2510998

Type

Journal article

Publication Date

2025-12-01T00:00:00+00:00

Volume

14

Addresses

P, r, o, g, r, a, m, , o, f, , I, m, m, u, n, o, l, o, g, y, , a, n, d, , I, m, m, u, n, o, t, h, e, r, a, p, y, ,, , C, i, m, a, , U, n, i, v, e, r, s, i, d, a, d, , d, e, , N, a, v, a, r, r, a, ,, , C, a, n, c, e, r, , C, e, n, t, e, r, , C, l, í, n, i, c, a, , U, n, i, v, e, r, s, i, d, a, d, , d, e, , N, a, v, a, r, r, a, , (, C, C, U, N, ), ,, , P, a, m, p, l, o, n, a, ,, , S, p, a, i, n, .

Keywords

Omentum, Animals, Humans, Mice, Peritoneal Neoplasms, RNA, Messenger, Cytokines, Immunotherapy, Immunomodulation